Cancel G, Abbas N, Stevanin G, et al: Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia/3 Machado-Joseph disease locus. Am J Hum Genet 57:809, 1995.
Carlson JD, Neumiller JJ, Swain LD, et al: Postoperative delirium in Parkinson’s disease patients following deep brain stimulation surgery. J Clin Neurosci 21: 1192, 2014.
Carroll WM, Mastaglia FL: Leber’s optic neuropathy. Brain 102:559, 1979.
Cedarbaum JM, Gandy SE, McDowell FH: “Early” initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson’s disease. Neurology 41:622, 1991.
Chin SS-M, Goldman JE: Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55:499, 1996.
Chio A, Benzi G, Dossena M, et al: Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472, 2005.
Chio A, Brignolio F, Leone M, et al: A survival analysis of 155 cases of progressive muscular atrophy. Acta Neurol Scand 72:407, 1985.
Clarke CE, Guttman M: Dopamine agonist monotherapy in Parkinson’s disease. Lancet 360:1767, 2002.
Cobb JL, Wolf PA, Au R, et al: The effect of education on the incidence of dementia and Alzheimer’s disease in the Framingham study. Neurology 45:1707, 1995.
Cohan SL, Kattah JC, Limaye SR: Familial tapetoretinal degeneration and epilepsy. Arch Neurol 36:544, 1979.
Colosimo C, Albanese A, Hughes AJ, et al: Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease. Arch Neurol 52:294, 1995.
Cooper IS: 20-year follow-up study of the neurosurgical treatment of dystonia musculorum deformans. In: Eldridge R, Fahn S (eds): Advances in Neurology. Vol 14: Dystonia. New York, Raven Press, 1976, pp 423–453.
Crane PK, Walker R, Hubbard RA, et al: Glucose levels and risk of dementia. N Engl J Med 369:540, 2013.
Creutzfeldt HG: Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z Gesamte Neurol Psychiatr 57:1, 1920.
Cross HE, McKusick VA: The mast syndrome. Arch Neurol 16:1, 1967.
Cudkowicz ME, McKenna-Yasek D, Chen C, et al: Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 43:703, 1998.
Cummings J, Isaacson S, Mills R , et al.: Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 383:533, 2014.